Search research articles
Contact Us
Filters
Showing results (411-420 of 445) with videos related to
Page
of 45
Sort By:
Cell
|
June 27, 2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins
Stephanie Berger, Franziska Seeger, Ta-Yi Yu, et al.
Nature
|
June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptors
Anusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature
|
November 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors
Anusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature
|
September 24, 2025
Design of facilitated dissociation enables timing of cytokine signalling
Adam J Broerman, Christoph Pollmann, Yang Zhao, et al.
Science (New York, N.Y.)
|
March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering
Xiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
FOXP3<sup>+</sup> regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissues
Hunter A Martinez, Ievgen Koliesnik, Gernot Kaber, et al.
Immunity
|
January 31, 2026
Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition
Paloma Navarro Negredo, Justin You, Max Hauptschein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2026
Design of solubly expressed miniaturized SMART MHCs
William L White, Hua Bai, Chan Jhong Kim, et al.
JCI Insight
|
July 18, 2024
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis
Michael A Paley, Xinbo Yang, Lynn M Hassman, et al.
Immunity
|
June 25, 2026
Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition
Paloma Navarro Negredo, Justin You, Max Hauptschein, et al.
Page
of 45
Search research articles
Search
Showing results (411-420 of 445) with videos related to
Sort By:
Page
of 45
Cell
|
June 27, 2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins
Stephanie Berger, Franziska Seeger, Ta-Yi Yu, et al.
Nature
|
June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptors
Anusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature
|
November 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors
Anusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature
|
September 24, 2025
Design of facilitated dissociation enables timing of cytokine signalling
Adam J Broerman, Christoph Pollmann, Yang Zhao, et al.
Science (New York, N.Y.)
|
March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering
Xiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
FOXP3<sup>+</sup> regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissues
Hunter A Martinez, Ievgen Koliesnik, Gernot Kaber, et al.
Immunity
|
January 31, 2026
Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition
Paloma Navarro Negredo, Justin You, Max Hauptschein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2026
Design of solubly expressed miniaturized SMART MHCs
William L White, Hua Bai, Chan Jhong Kim, et al.
JCI Insight
|
July 18, 2024
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis
Michael A Paley, Xinbo Yang, Lynn M Hassman, et al.
Immunity
|
June 25, 2026
Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition
Paloma Navarro Negredo, Justin You, Max Hauptschein, et al.
Page
of 45